A 58-year-old man from Mumbai presents to the neurology clinic with progressive weakness of the ocular muscles over 3 weeks. He reports diplopia and ptosis that worsens towards the evening. On examination, he has bilateral ptosis, ophthalmoplegia, and weakness of facial muscles. Repetitive nerve stimulation shows a decremental response. Serum antibodies against nicotinic acetylcholine receptors (AChR) are positive. Which of the following best explains the pathophysiology of his neuromuscular transmission defect?

Explanation

## Pathophysiology of Myasthenia Gravis (MG) **Key Point:** Myasthenia gravis is an autoimmune disorder where IgG antibodies bind to nicotinic acetylcholine receptors (AChR) at the neuromuscular junction, leading to receptor destruction, complement-mediated lysis, and cross-linking-induced internalization. ### Mechanism of Neuromuscular Transmission Failure 1. **Antibody-Mediated Destruction** - Anti-AChR antibodies (present in 80–90% of generalized MG cases) bind to the extracellular domain of AChR - Complement activation (C1q, C3, C5b-9) causes direct lysis of the postsynaptic membrane - Antibody cross-linking triggers receptor internalization and accelerated degradation 2. **Reduced Receptor Density** - Normal neuromuscular junction has ~1.5 million AChR per synapse - In MG, receptor density is reduced by 50–80% - This decreases the safety margin of neuromuscular transmission 3. **Functional Consequence** - Acetylcholine released from the presynaptic terminal is normal in quantity and timing - However, fewer receptors are available to bind ACh - Postsynaptic depolarization becomes subthreshold, especially with repetitive stimulation - This explains the **decremental response** on repetitive nerve stimulation (RNS) ### Clinical Correlation **High-Yield:** The **decremental response** (progressive decline in compound muscle action potential amplitude with repetitive stimulation) is pathognomonic for disorders of neuromuscular transmission and is seen in ~60% of ocular MG and >90% of generalized MG. **Clinical Pearl:** Symptoms worsen with **fatigue** (evening worsening) because repeated ACh release depletes the vesicular pool and further reduces the safety margin of transmission. ### Diagnostic Confirmation | Test | Finding in MG | |------|---------------| | Repetitive Nerve Stimulation | Decremental response (≥10% decline) | | Single-Fiber EMG | Increased jitter, blocking | | Anti-AChR Antibodies | Positive in 80–90% of generalized MG | | Anti-MuSK Antibodies | Positive in 40–50% of seronegative MG | | Edrophonium (Tensilon) Test | Transient improvement of weakness | **Mnemonic:** **ACE-R** = **A**ntibodies against **C**holinergic **E**ND-plate **R**eceptors → Reduced receptor density → Decreased safety margin → Decremental response. ### Why This Is NOT Presynaptic Dysfunction - Presynaptic disorders (e.g., Lambert-Eaton myasthenic syndrome, botulism) show **incremental response** on RNS or high-frequency stimulation - Acetylcholine synthesis and release are **normal** in MG - The defect is purely **postsynaptic** (receptor-level) [cite:Guyton & Hall Textbook of Medical Physiology 14e Ch 8; Harrison 21e Ch 380]